Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin
Article first published online: 14 NOV 2003
DOI: 10.1046/j.1365-2036.1997.00184.x
Additional Information
How to Cite
Lim, A. G., Walker, C., Chambers, S. and Gould, S. R. (1997), Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. Alimentary Pharmacology & Therapeutics, 11: 537–540. doi: 10.1046/j.1365-2036.1997.00184.x
Publication History
- Issue published online: 14 NOV 2003
- Article first published online: 14 NOV 2003
- Abstract
- References
- Cited By
Aim:
To evaluate the efficacy of a 7-day regimen of clarithromycin 250 mg b.d., amoxycillin 1 g b.d., and lansoprazole 30 mg b.d. as a treatment for Helicobacter pylori infection.
Methods:
H. pylori status of dyspeptic patients was assessed by 13C-urea breath test and at endoscopy by histology, culture and rapid urease testing of gastric biopsies. Fifty-one H. pylori-positive patients were treated with the above regimen. H. pylori status was reassessed by 13C -urea breath test not less than 28 days after completing treatment. Adverse events and compliance were evaluated.
Results:
On an intention-to-treat basis, H. pylori infection was cured in 77% (95% CI: 65–88%) of patients. Minor side-effects including diarrhoea, nausea and taste disturbance were reported by 64% of patients. Ninety-five per cent of patients consumed > 95% of tablets. Metronidazole resistance was 29% but all cultures were sensitive to amoxycillin and clarithromycin.
Conclusion:
This 7-day treatment with low-dose clarithromycin was moderately effective in curing H. pylori infection. Although compliance was excellent, there was a high frequency of minor adverse events.

1365-2036/asset/olbannerleft.gif?v=1&s=45db8c78d1d41c404034f2eaf7587620d5727843)
1365-2036/asset/olbannerright.gif?v=1&s=45518840b7e2e59fcc9d74113b13f4474a604878)
1365-2036/asset/cover.gif?v=1&s=d621428d7905f55dc6cbe431b6da6a6c8f16399c)